OTCMKTS:PANC

Panacos Pharmaceuticals Stock Forecast, Price & News

$0.0040

-0.01 (-61.90 %)

(As of 02/24/2021 02:28 PM ET)

Add

Compare

Today's Range

$0.00

Now: $0.00▼

$0.01

50-Day Range N/A

52-Week Range

$0.00

Now: $0.00▼

$0.04

Volume212,600 shs

Average Volume136,306 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

Beta6.62

Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its product candidate, bevirimat, which works by a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in December 1992 and is headquartered in Watertown, MA.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Biological products, except diagnostic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:PANC

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.panacos.com

Phone(617) 926-1551

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1808th out of 1,958 stocks

Biological Products, Except Diagnostic Industry

174th out of 177 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Panacos Pharmaceuticals.

0.0 Community Rank

Outperform Votes
Panacos Pharmaceuticals has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Panacos Pharmaceuticals has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Panacos Pharmaceuticals and other stocks. Vote “Outperform” if you believe PANC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PANC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Panacos Pharmaceuticals does not currently pay a dividend.
Dividend Growth
Panacos Pharmaceuticals does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Panacos Pharmaceuticals insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 6.90% of the stock of Panacos Pharmaceuticals is held by insiders.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$0.0040

-0.01 (-61.90 %)

(As of 02/24/2021 02:28 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive PANC News and Ratings via Email

Sign-up to receive the latest news and ratings for PANC and its competitors with MarketBeat's FREE daily newsletter.

Panacos Pharmaceuticals (OTCMKTS:PANC) Frequently Asked Questions

What stocks does MarketBeat like better than Panacos Pharmaceuticals?

Wall Street analysts have given Panacos Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Panacos Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Panacos Pharmaceuticals' key executives?

Panacos Pharmaceuticals' management team includes the following people:

John R. Barr, President & Chief Executive Officer
Thomas T. Higgins, Chief Financial Officer

Who are some of Panacos Pharmaceuticals' key competitors?

Some companies that are related to Panacos Pharmaceuticals include AVAX Technologies (AVXT), Cornwall Resources (CORC), Mymetics (MYMX), Neurobiological Technologies (NTII), Omni Bio Pharmaceutical (OMBP), Protide Pharmaceuticals (PPMD), Tengion (TNGNQ) and VIA Pharmaceuticals (VIAP).
View all of PANC's competitors.

What is Panacos Pharmaceuticals' stock symbol?

Panacos Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PANC."

How do I buy shares of Panacos Pharmaceuticals?

Shares of PANC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Panacos Pharmaceuticals' stock price today?

One share of PANC stock can currently be purchased for approximately $0.00.

What is Panacos Pharmaceuticals' official website?

The official website for Panacos Pharmaceuticals is www.panacos.com.

Where are Panacos Pharmaceuticals' headquarters?

Panacos Pharmaceuticals is headquartered at 134 COOLIDGE AVE, WATERTOWN MA, 02472.

How can I contact Panacos Pharmaceuticals?

Panacos Pharmaceuticals' mailing address is 134 COOLIDGE AVE, WATERTOWN MA, 02472. The company can be reached via phone at (617) 926-1551.

This page was last updated on 2/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here